Biochemical changes in rat liver in response to treatment with drugs and other agents. I. Effects of anticonvulsant, anti-inflammatory, hypocholesterolaemic and adrenergic beta-blocking agents.
D000083:Acetanilides / Q000494:pharmacology; D000632:Aminopyrine / Q000378:metabolism; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D000927:Anticonvulsants / Q000494:pharmacology*; D001463:Barbiturates; D001835:Body Weight / Q000187:drug effects; D002087:Butyrates / Q000494:pharmacology; D003580:Cytochromes; D003593:Cytoplasm / Q000032:analysis; D004579:Electron Transport; D005952:Glucose-6-Phosphatase / Q000378:metabolism; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D005969:Glutamate Dehydrogenase / Q000378:metabolism; D007213:Indomethacin / Q000494:pharmacology; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008099:Liver / Q000033:anatomy & histology / Q000187:drug effects* / Q000201:enzymology; D008297:Male; D008861:Microsomes / Q000032:analysis / Q000201:enzymology; D009929:Organ Size; D010088:Oxidoreductases / Q000378:metabolism; D010634:Phenobarbital / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D010734:Phosphogluconate Dehydrogenase / Q000378:metabolism; D011433:Propranolol / Q000494:pharmacology; D011506:Proteins / Q000032:analysis; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology*
D000083:Acetanilides; D000893:Anti-Inflammatory Agents; D000924:Anticholesteremic Agents; D000927:Anticonvulsants; D001463:Barbiturates; D002087:Butyrates; D003580:Cytochromes; D011506:Proteins; D013565:Sympatholytics; D000632:Aminopyrine; D010672:Phenytoin; D011433:Propranolol; D010088:Oxidoreductases; D007770:L-Lactate Dehydrogenase; D010734:Phosphogluconate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D005969:Glutamate Dehydrogenase; D005952:Glucose-6-Phosphatase; D010653:Phenylbutazone; D007213:Indomethacin; D010634:Phenobarbital